News
glaucoma
Biomarkers identified that can predict glaucoma patients' risk of vision loss
Glaucoma affects more than 4 million adults in the United States and it is the leading cause of vision loss in the world. Even with the current treatments available, some patients still lose vision.
age-related macular degeneration
First true vision correction smartglasses have been developed
Soliddd Corporation has developed SolidddVision™ smartglasses for use by people suffering from vision loss due to macular degeneration.
age-related macular degeneration
Overproduction of a protein may hold the key to a cure for AMD
Researchers recently discovered a protein that seems to play a critical role in the onset of age-related macular degeneration (AMD).
blurry vision
4 Red flags with your vision you should not ignore
While a yearly, comprehensive eye exam is the first line of defense in taking care of our eyes, here are four symptoms that should not be overlooked.
age related macular degeneration
Something out of science fiction: solar panels for the eyes
With new treatments and scientific advancements being announced almost on a daily basis, it shouldn't be surprising that the next "big thing" might very well be tiny solar panels for the eyes.
cataract surgery
Non-surgical treatment for cataracts being developed
A team of international researchers at the Anglia Ruskin University took on the task of looking into using an oxysterol compound as a non-surgical option for cataracts.
glaucoma
BELKIN Vision announces FDA approval of new glaucoma laser device
With more than 3.6 million patients in the United States living with a diagnosis of glaucoma, this new laser offers the first and only contactless laser for glaucoma.
Decorative contact lenses
Avoid a scary eye infection with these safe Halloween tips
Halloween is right around the corner and it's important to know about eye safety when it comes to selecting your costume.
age related macular degeneration
Phase 2b clinical trials set for potential AMD treatment
More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...